What is the ticker symbol for CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited trades under the ticker GDTC on NASDAQ.

What sector does CytoMed Therapeutics Limited operate in?

CytoMed Therapeutics Limited is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GDTC in a portfolio?

PortView shows GDTC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

CytoMed Therapeutics Limited (GDTC) Stock Analysis

NASDAQHealthcareBiotechnology

$0.89-2.13%

1-year price historyRange $0.72 – $2.69

52-week range$0.89

$0.68$3.68

What CytoMed Therapeutics Limited does

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.

Key metrics

Market cap

$10.52M

P/E (TTM)

-4.12

EPS (TTM)

$-0.22

Beta

0.05

Dividend yield

0.00%

Revenue / share

$0.05

50-day avg

$0.94

200-day avg

$1.13

52-week high

$3.68

52-week low

$0.68

CEO

Chee Kong Choo

ETFs linked to GDTC

Broad-market and Healthcare sector ETFs an investor holding CytoMed Therapeutics Limited is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GDTC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GDTC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for CytoMed Therapeutics Limited?: CytoMed Therapeutics Limited trades under the ticker GDTC on NASDAQ.
Which exchange is GDTC listed on?: GDTC is listed on NASDAQ.
What sector does CytoMed Therapeutics Limited operate in?: CytoMed Therapeutics Limited is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GDTC in a portfolio?: PortView shows GDTC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.